Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 23, 2016

Primary Completion Date

November 14, 2019

Study Completion Date

December 22, 2023

Conditions
Muscular Atrophy, Spinal
Interventions
DRUG

Risdiplam

Risdiplam will be administered orally.

Trial Locations (32)

3000

UZ Leuven Gasthuisberg, Leuven

4000

Chr de La Citadelle, Liège

4005

Universitäts-Kinderspital (UKBB) Neuropädiatrie, Basel

9000

UZ Gent, Ghent

10000

Clinical Medical Center Zagreb; University Hospital Rebro Department of Paediatrics, Zagreb

10032

Columbia University Medical Center; The Neurological Institute of New York, New York

11000

Institute for Mother and Child Dr. Vukan Cupic, Belgrade

11211

King Faisal Specialist Hospital and Research Centre Building, Riyadh

16147

IRCCS Istituto Giannina Gaslini; U.O.S.D. Centro di Miologia e Patologie Neurodegenerative, Genoa

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Unità Operativa Complessa di Neurologia, Milan

20133

Fondazione IRCCS Istituto Neurologico ?Carlo Besta?; UO di Neurologia dello Sviluppo, Milan

34752

Hospital Yeditepe University Kozyatagi; Pediatry, Atasehir- Istanbul

41013

Hospital Universitario Virgen del Rocio, Seville

60611

Ann and Robert H. Lurie Children Hospital of Chicago, Chicago

61068

Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology, Kharkiv

69677

Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique ? L?ESCALE, Bron

75571

Hopital Armand Trousseau, Paris

94304

Stanford University Medical Center, Palo Alto

100034

Peking University First Hospital, Beijing

125412

Russian Children Neuromuscular Center of Veltischev, Moscow

201102

Children's Hospital of Fudan University, Shanghai

02115

Boston Childrens Hospital, Boston

CEP 21941-912

Instituto de Puericultura E Pediatria Martagão Gesteira, Rio de Janeiro

05403-000

Hospital das Clinicas - FMUSP_X; Neurologia, São Paulo

00165

IRCCS Ospedale Pediatrico Bambino Gesù; U.O. Malattie Neuromuscolari e Neurodegenerative, Rome

00168

Policlinico Agostino Gemelli; Dipartimento di Neuropsichiatria Infantile, Rome

663-8501

Hyogo Medical University Hospital, Hyōgo

80-952

Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology, Gda?sk

04-730

The Children?s Memorial Health Institute Department of Neurology and Epileptology, Warsaw

08950

Hospital Sant Joan De Deu, Esplugues de Llobregas

08035

Hospital Universitari Vall d'Hebron; Area Genética Clínica y Molecular, Barcelona

06100

Hacettepe University, School of Medicine; Pediatrics Department; Pediatrics Child Neurology Unit, Ankara

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02913482 - Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy | Biotech Hunter | Biotech Hunter